nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2018-22-3-18-25nefr-361Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESОСОБЕННОСТИ РАЗВИТИЯ, ТЕЧЕНИЯ И ИСХОДА ОСТРОГО ПОВРЕЖДЕНИЯ ПОЧЕК ПОСЛЕ ТРАНСПЛАНТАЦИИ ГЕМОПОЭТИЧЕСКИХ СТВОЛОВЫХ КЛЕТОК У ДЕТЕЙ (ОБЗОР ЛИТЕРАТУРЫ)FEATURES OF DEVELOPMENT, COURSE AND OUTCOME OF ACUTE KIDNEY INJURY AFTER HEMOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN (LITERATURE REWIEV)ХарисоваЭ. Р.KharisovaE. R.

кафедра факультетской педиатрии, клинический ординатор

MD, StPetersburg State Pediatric Medical University Department of faculty pediatrics

СавенковаН. Д.SavenkovaN. D.

д-р мед. наук, Санкт- Петербургский государственный педиатрический медицинский университет, кафедра факультетской педиатрии, заведующая кафедрой

State Pediatric Medical Department of faculty pediatrics University

Savenkova.n.spb@mail.ruСанкт-Петербургский государственный педиатрический медицинский университетРоссияSt-Petersburg State Pediatric Medical UniversityRussian Federation2018120520182231825Copyright © Харисова Э.Р., Савенкова Н.Д., 20182018Харисова Э.Р., Савенкова Н.Д.Kharisova E.R., Savenkova N.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/361

В обзоре литературы представлены эпидемиология, причины, особенности развития, течения и исхода острого почечного повреждения после трансплантации гемопоэтических стволовых клеток у детей.

 

In literature review are presented the epidemiology, causes, features of courses, outcome of acute kidney injury after hemopoietic stem cell transplantation in children.

детитрансплантация гемопоэтических стволовых клетокострое повреждение почекchildrenhemopoietic stem cell transplantationacute kidney injuryReferencesАфанасьев БВ, Зубаровская ЛС, Моисеев ИС. Аллогенная трансплантация гемопоэтических стволовых клеток у детей: настоящее, проблемы, перспективы. Российский журнал детской гематологии и онкологии 2015; 2: 28–42 DOI: 10.17650/2311-1267-2015-2-2-28-42Afanasev BV, Zubarovskaya LS, Moiseev IS. Allogennaya transplantaciya gemopoehticheskih stvolovyh kletok u detej-nastoyashchee problemy perspektivy. Rossijskij zhurnal detskoj gematologii i onkologii2015; 2: 28–42 DOI: 10.17650/2311-1267-2015-2-2-28-42Зубаровская ЛС, Афанасьев БВ. Трансплантация гемопоэтических стволовых клеток при гематологических заболеваниях. В: Афанасьев БВ, Волкова ОЯ, Ганапиев АА и др. Гематология. Руководство для врачей. СпецЛит, СПб.:, 2011; 537–591Zubarovskaya LS, Afanas’ev BV. Transplantaciya gemopoehticheskih stvolovyh kletok pri gematologicheskih zabolevaniyah. Gematologiya. Rukovodstvo dlya vrachej. Afanas’ev BV, Volkova OYа, Ganapiev AA i dr. SPb.: SpecLit, 2011; 537–591Смирнов КА. Острое повреждение почек после трансплантации гемопоэтических стволовых клеток. Смирнов АВ, Добронравов ВА, Румянцев АШ, Каюков ИГ. Острое повреждение почек. Медицинское информационное агенство, М., 2015; 446–467Smirnov KA. Ostroe povrezhdenie pochek posle transplantacii gemopoehticheskih stvolovyh kletok. Smirnov AV, Dobronravov VA, Rumyancev ASH, Kayukov IG. Ostroe povrezhdenie pochek. Medicinskoe informacionnoe agenstvo, М., 2015; 446–467Смирнов КА, Добронравов ВА. Острое повреждение почек при трансплантации гемопоэтических стволовых клеток. Нефрология 2014; 6: 26–42Smirnov KA, Dobronravov VA. Ostroe povrezhdenie pochek pri transplantacii gemopoehticheskih stvolovyh kletok. Nefrologiya 2014; 6:26–42Zager RA, O’Quigley J, Zager BK et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis1989; 13:210–216Zager RA, O’Quigley J, Zager BK et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis1989; 13:210–216Lane PH, Mauer SM, Blazar BR et al. Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 1994; 13:613–617Lane PH, Mauer SM, Blazar BR et al. Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 1994; 13:613–617Raina R, Herrera N, Krishnappa V et al. Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. Pediatr Transplant 2017; 21(4):1–14. DOI:10.1111/petr.12935Raina R, Herrera N, Krishnappa V et al. Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. Pediatr Transplant 2017; 21(4):1–14. DOI:10.1111/petr.12935Hazar V, Gungor O, Guven AG et al. Renal function after hematopoietic stem cell transplantation in children. Pediatric Blood & Cancer 2009; 53:197–202Hazar V, Gungor O, Guven AG et al. Renal function after hematopoietic stem cell transplantation in children. Pediatric Blood & Cancer 2009; 53:197–202Kist-van Holthe JE, Goedvolk CA, Brand R et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002; 17:1032–1037Kist-van Holthe JE, Goedvolk CA, Brand R et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002; 17:1032–1037Patzer L, Kentouche K, Ringelmann F et al Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 2003; 18:623–635Patzer L, Kentouche K, Ringelmann F et al Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 2003; 18:623–635Kist-van Holthe JE, van Zwet JM, Brand R et al. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998; 22:559–564Kist-van Holthe JE, van Zwet JM, Brand R et al. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998; 22:559–564Ileri T, Ertem M, Ozcakar ZB et al. Prospective evaluation of acute and chroniс renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatr Transplant 2010; 14: 138–144Ileri T, Ertem M, Ozcakar ZB et al. Prospective evaluation of acute and chroniс renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatr Transplant 2010; 14: 138–144Kizilbash SJ, Kashtan CE, Chavers B et al. Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016 Jul; 22 (7):1264–1270. doi: 10.1016/j.bbmt.2016.03.014Kizilbash SJ, Kashtan CE, Chavers B et al. Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016 Jul; 22 (7):1264–1270. doi: 10.1016/j.bbmt.2016.03.014Koh K-N, Sunkara A, Kang G. Acute et al. Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes. Biology of Blood and Marrow Transplantation 2017; doi.org/10.1016/j. bbmt.2017.11.021Koh K-N, Sunkara A, Kang G. Acute et al. Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes. Biology of Blood and Marrow Transplantation 2017; doi.org/10.1016/j. bbmt.2017.11.021Савенкова НД, Панков ЕА. Нерешенные проблемы острого почечного повреждения у детей. Нефрология 2015; 19 (3):9–19Savenkova ND, Pankov EA. Nereshennye problemy ostrogo pochechnogo povrezhdeniya u detej. Nefrologiya 2015; 19(3):9-19Чухловин АБ, Ширяев СН, Вавилов ВН и др. Реактивация цитомегаловиурсной инфекции после трансплантации гемопоэтических стволовых клеток: зависимость от возраста и интенсивности кондиционирующей терапии.Клинико-лабораторный консилиум 2012; 2 (42): 63–67Chukhlovin AB, Shiryaev SN, Vavilov VN i dr. Reaktivaciya-citomegaloviursnoj infekcii posle transplantacii gemopoehticheskih stvolovyh kletok zavisimost ot vozrasta i intensivnosti kondicioniruyushchej terapii. Kliniko laboratornyj konsilium 2012; 2 (42): 63–67Lunde LE, Dasaraju S, Cao Q. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant 2015 Nov; 50 (11): 1432–1437. doi: 10.1038/bmt.2015.162Lunde LE, Dasaraju S, Cao Q. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant 2015 Nov; 50 (11): 1432–1437. doi: 10.1038/bmt.2015.162Kloos RQ, Boelens JJ, de Jong TP. Hemorrhagic cystitis in a cohort of pediatric transplantations: incidence, treatment, outcome, and risk factors. Biol Blood Marrow Transplant 2013; 19(8): 1263–1266.doi: 10.1016/j.bbmt.2013.05.014.Kloos RQ, Boelens JJ, de Jong TP. Hemorrhagic cystitis in a cohort of pediatric transplantations: incidence, treatment, outcome, and risk factors. Biol Blood Marrow Transplant 2013; 19(8): 1263–1266.doi: 10.1016/j.bbmt.2013.05.014.Jodele S, Davies SM, Lane A et al. Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults. Blood 2014; 124 (4): 645–653Jodele S, Davies SM, Lane A et al. Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults. Blood 2014; 124 (4): 645–653Jodele S, Dandoy CE, Myers KC et al. New approaches in the diagnosis, pathophysiologyand treatment of pediatric hematopoieticstem cell transplantation-associated thrombotic micro-angiopathy. Transfus Apher Sci 2016 Apr; 54(2):181–190. doi: 10.1016/j.transci.2016.04.007Jodele S, Dandoy CE, Myers KC et al. New approaches in the diagnosis, pathophysiologyand treatment of pediatric hematopoieticstem cell transplantation-associated thrombotic micro-angiopathy. Transfus Apher Sci 2016 Apr; 54(2):181–190. doi: 10.1016/j.transci.2016.04.007Laskin BL, Maisel J, Goebel J et al. Renal arteriolar C4d deposition: a novel characterist of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 2013; 96:217–223Laskin BL, Maisel J, Goebel J et al. Renal arteriolar C4d deposition: a novel characterist of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 2013; 96:217–223Ho VT, Cutler C, Carter S et al. Blood and marrow transplant clinicaltrials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11: 571–575Ho VT, Cutler C, Carter S et al. Blood and marrow transplant clinicaltrials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11: 571–575Lerner D, Dandoy C, Hirsch R et al.Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Bone Marrow Transplant 2014; 49:862–863Lerner D, Dandoy C, Hirsch R et al.Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Bone Marrow Transplant 2014; 49:862–863Jodele S, Laskin BL, Dandoy CE et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 2015; 29:191–204Jodele S, Laskin BL, Dandoy CE et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 2015; 29:191–204Siami K, Kojouri K, Swisher KK et al. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008; 85:22–28Siami K, Kojouri K, Swisher KK et al. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008; 85:22–28Jodele S, Fukuda T, Mizuno K. Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016;22(2):307–315Jodele S, Fukuda T, Mizuno K. Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016;22(2):307–315Пристанскова ЕА, Киргизов КИ, Сидорова НВ и др. Случай успешной терапии ритуксимабом вторичного гемолитико-уремического синдрома у пациента после повторной аллогенной трансплантации гемопоэтических стволовых клеток. Российский журнал детской гематологии и онкологии 2016; 3(3): 61–65Pristanskova EA, Kirgizov KI, Sidorova NV i dr. Sluchaj uspeshnoj terapii rituksimabom vtorichnogo gemolitikouremicheskogo sindroma u pacienta posle povtornoj allogennoj transplantacii gemopoehticheskih stvolovyh kletok. Rossijskij zhurnal detskoj gematologii i onkologii 2016; 3(3): 61–65Abusin GA, Abu-Arja R, Bajwa RPS. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies. Pediatr Blood Cancer 2017;64(9). doi: 10.1002/ pbc.26503Abusin GA, Abu-Arja R, Bajwa RPS. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies. Pediatr Blood Cancer 2017;64(9). doi: 10.1002/ pbc.26503Громова ЕГ, Кузнецова ЛС. Синдром лизиса опухоли: патогенез, клиника, профилактика, лечение. Онкология 2007; (3):61–64.6Gromova EG, Kuznetsova LS. Sindrom lizisa opuholi patogenez, klinika, profilaktika, lechenie. Onkologiya 2007 (3): 61–64.6Basile C, Montanaro A. An exceptionally severe hyper-uricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS). G Ital Nephrol 2003; 20(5):525–528Basile C, Montanaro A. An exceptionally severe hyper-uricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS). G Ital Nephrol 2003; 20(5):525–528Новичкова ГА, Птушкин ВВ, Румянцев АГ. Клинические рекомендации по профилактике и лечению синдрома лизиса опухоли у детей и подростков. Российский журнал детской гематологии и онкологии 2014; 4: 37–50Novichkova GA, Ptushkin VV., Rumyantsev AG. Klinicheskie rekomendacii po pro-filaktike i lecheniyu sindroma lizisa opuholi u detej i podrostkov 2014; 4: 37–50Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis 2007; 2:35Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis 2007; 2:35Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 2008;41(2):58–64Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 2008;41(2):58–64Homma CI, Kami M, Masuo S et al. Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 May; 35(9):929–930Homma CI, Kami M, Masuo S et al. Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 May; 35(9):929–930Panoskaltsis-Mortari A, Price A, Hermanson JR et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103: 3590–3598Panoskaltsis-Mortari A, Price A, Hermanson JR et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103: 3590–3598Pidala J. Graft-vs-host disease following allogeneic he-matopoietic stem cell transplantation. Cancer Control 2011; 18 (4): 268–276Pidala J. Graft-vs-host disease following allogeneic he-matopoietic stem cell transplantation. Cancer Control 2011; 18 (4): 268–276Porter GA, Palmer BF, Henrich WL. Clinical relevance In: DeBroe ME, Porter GA, Bennett WM, Verpooten GA eds. Clinical nephrotoxins: Renal injury from drugs and chemicals, 2nd ed Dordrecht: Kluwer Academic, 2003; 3–20Porter GA, Palmer BF, Henrich WL. Clinical relevance In: DeBroe ME, Porter GA, Bennett WM, Verpooten GA eds. Clinical nephrotoxins: Renal injury from drugs and chemicals, 2nd ed Dordrecht: Kluwer Academic, 2003; 3–20Савенкова НД, Чемоданова МА, Панков ЕА. Острое повреждение почек у детей. Нефрология 2013;17(4):26-35Savenkova ND, Chemodanova MA, Pankov EA. Ostroe povrezhdenie pochek u detej. Nefrologiya 2013;17(4):26–35Cordero C, Loboda C, Clerc-Urmès I et al. Unexpected acute renal injury after highdose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2017; 64(12). doi: 10.1002/ pbc.26669Cordero C, Loboda C, Clerc-Urmès I et al. Unexpected acute renal injury after highdose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2017; 64(12). doi: 10.1002/ pbc.26669Baird K, Cooke K, Kirk R Schultz. Chronic Graft Versus Host Disease (GVHD) in Children. Pediatr Clin North Am 2010 Feb; 57(1): 297–322Baird K, Cooke K, Kirk R Schultz. Chronic Graft Versus Host Disease (GVHD) in Children. Pediatr Clin North Am 2010 Feb; 57(1): 297–322Zhang C, Todorov I, Zhang Z et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006; 107(7):2993–3001Zhang C, Todorov I, Zhang Z et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006; 107(7):2993–3001Colombo AA, Rusconi C, Esposito C et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation 2006; 27;81(8):1087–1092Colombo AA, Rusconi C, Esposito C et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation 2006; 27;81(8):1087–1092Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010; 16: 157–168Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010; 16: 157–168Parmar V, Lewis M, Shenoy M. Ascitic fluid drainage using a peritoneal dialysis catheter to prevent and treat multi-organ dysfunction in veno-occlusive disease in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2017; 64(9) doi: 10.1002/pbc.26469Parmar V, Lewis M, Shenoy M. Ascitic fluid drainage using a peritoneal dialysis catheter to prevent and treat multi-organ dysfunction in veno-occlusive disease in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2017; 64(9) doi: 10.1002/pbc.26469Thomas SE, Hutchinson RJ, DebRoy M, Magee JC. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 2004;8:507–512Thomas SE, Hutchinson RJ, DebRoy M, Magee JC. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 2004;8:507–512

The authors declare that there are no conflicts of interest present.